01-Sep-25 |
Sell |
Giles Wilson |
91.08p | 30,000 |
£27,324.69 |
01-Sep-25 |
Buy |
Giles Wilson |
91.15p | 30,019 |
£27,360.73 |
01-Sep-25 |
Sell |
Giles Wilson |
89.65p | 105,785 |
£94,836.25 |
01-Sep-25 |
Buy |
Giles Wilson |
91.38p | 105,838 |
£96,711.59 |
01-Sep-25 |
Buy |
Giles Wilson |
91.38p | 105,838 |
£96,711.59 |
01-Sep-25 |
Sell |
Giles Wilson |
89.65p | 105,785 |
£94,836.25 |
01-Sep-25 |
Buy |
Giles Wilson |
91.15p | 30,019 |
£27,360.73 |
01-Sep-25 |
Sell |
Giles Wilson |
91.08p | 30,000 |
£27,324.69 |
Paul Mason |
7,875,000 |
£7,052,062 |
Giles Wilson |
230,193 |
£206,138 |
Robyn Perriss |
94,328 |
£84,471 |
Andrew Harrison |
76,594 |
£68,590 |
Lynne Weedall |
40,054 |
£35,868 |
Ian Rogers |
20,270 |
£18,152 |
Ije Nwokori |
6,559 |
£5,874 |
IngreLux S.àr.l |
369,942,440 |
£331,283,455 |
IngreGrsy Limited |
369,942,440 |
£331,283,455 |
Permira Holdings Limited |
364,142,440 |
£326,089,555 |
Artemis Investment Management LLP |
86,997,521 |
£77,906,280 |
Fidelity Management & Research |
32,500,000 |
£29,103,750 |
Intertrust Employee Benefit Trustee Limited |
135,000 |
£120,892 |
|
Final |
Interim |
Ex-Div |
28-Aug-25 |
06-Mar-25 |
Paid |
08-Oct-25 |
08-Apr-25 |
Amount |
1.70p |
0.85p |
10:35 |
547 @ 89.55p |
10:35 |
1,068 @ 89.50p |
10:35 |
1,015 @ 89.50p |
10:31 |
290 @ 89.70p |
10:29 |
300 @ 89.30p |
Chair |
Paul Mason |
CEO |
Ije Nwokori |
CFO |
Giles Wilson |
Top of Page
You are here:
research